Skip to main content
Clinical Trials/CTRI/2019/04/018418
CTRI/2019/04/018418
Not yet recruiting
未知

Trazodone for sleep disturbance in opioid dependent patients maintained on buprenorphine:a double blind placebo controlled trial

ALL INDIA INSTITUTE OF MEDICAL SCIENCES0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: F112- Opioid dependence
Sponsor
ALL INDIA INSTITUTE OF MEDICAL SCIENCES
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1Male gender
  • 2Age 18 to 60 years
  • 3Literate (able to read and write)
  • 4Registered in NDDTC OPD/community clinics
  • 5Initiated on buprenorphine (BPN) / BPN\-Naloxone (BPN\-N) at least three months prior to intervention for treatment of Opioid Dependence Syndrome
  • 6Maintained on a stable dose (dose change not more than two milligram per day) of buprenorphine/buprenorphine\-naloxone for last one month
  • 7Adherent on BPN / BPN\-N (for at least 50% occasions in last one month)
  • 8Total scores on Pittsburgh Sleep Quality Index \> 5

Exclusion Criteria

  • 1History of co\-morbid psychiatric illnesses, except sleep disorders (as per MINI\-7 Screen) in last one month.
  • 2Use of any other non\-prescribed psychoactive substances, except nicotine, cannabis, alcohol and caffeine, in last one month
  • 3Cannabis and alcohol use in â??high\-riskâ?? category (as per WHO\-ASSIST score)
  • 4On other psychotropic medications (except buprenorphine/BPN\-N) in the past one month
  • 5Diagnosed case of chronic physical illnesses (such as HTN, Coronary Artery Disease, Chronic Kidney Disease, Chronic Liver Disease, Endocrine diseases including DM, COPD, etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials